Gastroesophageal reflux disease and irritable bowel syndrome: A common overlap syndrome

被引：24
作者：
Dickman R. [1 ]
Feroze H. [1 ]
Fass R. [1 ]
机构：
[1] Neuro-Enteric Clinical Research Group, Southern Arizona VA Health Care System, Tucson, AZ 85723-0001
来源：
Current Gastroenterology Reports | 2006年 / 8卷 / 4期
关键词：
Irritable Bowel Syndrome; Functional Dyspepsia; GERD Symptom; Erosive Esophagitis; Proton Pump Inhibitor Therapy;
D O I：
10.1007/s11894-006-0045-1
中图分类号：
学科分类号：
摘要：
Gastroesophageal reflux disease (GERD) and irritable bowel syndrome (IBS) are very common disorders in the general population. Symptoms of IBS are commonly encountered in GERD patients, and symptoms of GERD are not uncommon in IBS patients. GERD patients consistently report lower abdominal symptoms, which may be part of the spectrum of GERD symptoms. Alternatively, GERD and IBS may be two distinct manifestations of a similar underlying pathophysiologic process that can affect different levels of the gastrointestinal tract. Although the reason for the overlap observed between GERD and IBS remains to be elucidated, recent studies have demonstrated that GERD patients who also suffer from IBS-like symptoms perceive their GERD-related symptoms as more severe and are less likely to respond to antireflux treatment, as compared with those without IBS. Copyright © 2006 by Current Science Inc.
引用
收藏
页码：261 / 265
页数：4
相关论文
共 28 条
  • [11] Smart H.L., Nicholson D.A., Atkinson M., Gastro-oesophageal reflux in the irritable bowel syndrome, Gut, 27, pp. 1127-1131, (1986)
  • [12] Guillemot F., Ducrotte P., Bueno L., Prevalence of functional gastrointestinal disorders in a population of subjects consulting for gastroesophageal reflux disease in general practice, Gastroenterol Clin Biol, 29, pp. 243-246, (2005)
  • [13] Stanghellini V., Armstrong D., Monnikes H., Et al., Determination of ReQuest-based symptom thresholds to define symptom relief in GERD clinical studies, Digestion, 71, pp. 141-145, (2005)
  • [14] Zimmerman J., Irritable bowel, smoking and oesophageal acid exposure: An insight into the nature of symptoms of gastro-oesophageal reflux, Aliment Pharmacol Ther, 20, pp. 1297-1303, (2004)
  • [15] Bardhan K.D., Stanghellini V., Armstrong D., Et al., Evaluation of GERD symptoms during therapy. Part I. Development of the new GERD questionnaire ReQuest, Digestion, 69, pp. 229-237, (2005)
  • [16] Bardhan K.D., Stanghellini V., Armstrong D., Et al., International validation of ReQuest in patients with endoscopy-negative gastro-oesophageal reflux disease, Aliment Pharmacol Ther, 20, pp. 891-898, (2004)
  • [17] Fass R., Stanghellini V., Monnikes H., Et al., Baseline analysis of symptom spectrum in GERD clinical trial patients: Results from the ReQuest database, Gastroenterology, 130, 4 SUPPL. 2, (2006)
  • [18] Talley N.J., Dennis E.H., Schettler-Duncan V., Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea, Am J Gastroenterol, 98, pp. 2454-2459, (2003)
  • [19] Zimmerman J., Extraintestinal symptoms in irritable bowel syndrome and inflammatory bowel diseases: Nature, severity, and relationship to gastrointestinal symptoms, Dig Dis Sci, 48, pp. 743-749, (2003)
  • [20] Papatheodoridis G.V., Karamanolis D.G., Prevalence and impact of upper and lower gastrointestinal symptoms in the Greek urban general population, Scand J Gastroenterol, 40, pp. 412-421, (2005)
123